Impaired potentiation by endothelin-1 and vasopressin of sympathetic contraction in tail artery from hypertensive rats

Cardiovascular Research

Volumn 45, Issue 2, 2000, Pages 463-469

  García Villalón, Angel Luis ^a   Monge, Luis ^a   Fernández, Nuria ^a   Sánchez, Miguel Angel ^a   Martínez, María Angeles ^a   Gómez, Bernardino ^a   Diéguez, Godofredo ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Adrenergic (ant)agonists; Arteries, Ca channel; Endothelins; Hypertension; Receptors

Indexed keywords

CALCIUM CHANNEL; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DESMOPRESSIN; ENDOTHELIN 1; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; PHENTOLAMINE; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE]; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V2 RECEPTOR; VERAPAMIL;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; DRUG POTENTIATION; HYPERTENSION; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC TONE; TAIL ARTERY; VASOCONSTRICTION;

ANIMALS; ARGININE VASOPRESSIN; CALCIUM CHANNEL BLOCKERS; ELECTRIC STIMULATION; ENDOTHELIN-1; HYPERTENSION; MALE; NOREPINEPHRINE; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PIPERIDINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ENDOTHELIN; RECEPTORS, VASOPRESSIN; VASOCONSTRICTION; VASOPRESSINS; VERAPAMIL;

EID: 0342546001     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00279-5     Document Type: Article

References (26)

1. Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 62:1982;347-504.
2. Tomobe Y., Ishikawa T., Yanagisawa M., et al. Mechanisms of altered sensitivity to endothelin-1 between aortic smooth muscles of spontaneously hypertensive and Wistar-Kyoto rats. J Pharmacol Exp Ther. 257:1991;555-561.
3. Miki S., Takeda K., Kiyama M., et al. Augmented response of endothelin-A and endothelin-B receptor stimulation in coronary arteries of hypertensive hearts. J Cardiovasc Pharmacol. 31:(Suppl. 1):1998;S94-S98.
4. Dohi Y., Lüscher T.F. Endothelin in hypertensive resistance arteries. Intraluminal and extraluminal dysfunction. Hypertension. 18:1991;543-549.
5. Nguyen P.V., Parent A., Deng L.Y., et al. Endothelin vascular receptors and responses in deoxycorticosterone acetate-salt hypertensive rats. Hypertension. 19:(Suppl. II):1992;II98-II104.
6. Bolger G.T., Liard F., Jodoin A., Jaramillo J. Vascular reactivity, tissue levels and binding sites for endothelin: a comparison in the spontaneously hypertensive and Wistar-Kyoto rats. Can J Physiol Pharmacol. 69:1991;406-413.
7. Schiffrin E.L., Deng L.Y., Larochelle P. Blunted effects of endothelin on small subcutaneous resistance arteries of mild essential hypertensive patients. J Hypertens. 10:1992;437-444.
8. 1 receptors. Am J Physiol. 271:1996;F304-F313.
9. Stallone J.N. Mesenteric vascular responses to vasopressin during development of DOCA-salt hypertension in male and female rats. Am J Physiol. 268:1995;R40-R49.
10. Schiffrin E.L. Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension. 25:1995;1135-1143.
11. 2 receptor antagonism in young SHR. Am J Physiol. 272:1997;F229-F234.
12. Wiklund N.P., Ohlen A., Wiklund C.U., Cederqvist B. Adrenergic neuromodulation by endothelin in guinea-pig pulmonary artery. Neurosci Lett. 101:1989;269-274.
13. García-Villalón A.L., Padilla J., Monge L., et al. Role of the endothelin receptors, calcium and nitric oxide in the potentiation by endothelin-1 of the sympathetic contraction of rabbit ear artery during cooling. Br J Pharmacol. 121:1997;1659-1664.
14. Bartlestone H.J., Nasmyth P.A., Telford J.M. The significance of adenosine cyclic 3′5′-monophosphate for the contraction of smooth muscle. J Physiol (Lond). 188:1967;159-176.
15. García-Villalón A.L., Padilla J., Monge L., et al. Effects of vasopressin on the sympathetic contraction of rabbit ear artery during cooling. Br J Pharmacol. 126:1999;785-793.
16. Tabuchi Y., Nakamary M., Rakugi H., et al. Effects of endothelin on neuroeffector junction in mesenteric arteries of hypertensive rats. Hypertension. 15:1990;739-743.
17. Dohi Y., Hahn A.W.A., Boulanger C.M., Bühler F.R., Lüscher T.F. Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension. 19:1992;131-137.
18. Cassis L.A., Stitzel R.E., Head R.J. Hypernoradrenergic innervation of the caudal artery of the spontaneously hypertensive rat: an influence upon neuroeffector mechanisms. J Pharmacol Exp Ther. 234:1985;792-803.
19. Doggrell S.A., Brown L. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res. 39:1998;89-105.
20. Pinto Y.M., Paul M., Ganten D. Lessons from rat models of hypertension: from Goldblatt to genetic engineering. Cardiovasc Res. 39:1998;77-88.
21. Padilla J., García-Villalón A.L., Monge L., et al. Peptidergic modulation of the sympathetic contraction in the rabbit ear artery: effects of temperature. Br J Pharmacol. 121:1997;21-28.
22. Mutafova-Yambolieva V.N., Westfall D.P. Inhibitory and facilitatory presynaptic effects of endothelium on sympathetic cotransmission in the rat isolated tail artery. Br J Pharmacol. 123:1998;136-142.
23. Medina P., Noguera I., Aldasoro M., et al. Enhancement by vasopressin of adrenergic responses in human mesenteric arteries. Am J Physiol. 272:1997;H1087-H1093.
24. Larivière R., Thibault G., Schiffrin E.L. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension. 21:1993;294-300.
25. Miyamori I., Takeda Y., Yoneda T., Takeda R. Endothelin-1 release from mesenteric arteries of spontaneously hypertensive rats. J Cardiovasc Pharmacol. 17:1991;S408-S410.
26. Crofton J.T., Share L., Shade R.E., Allen C., Tarnowski D. Vasopressin in the rat with spontanous hypertension. Am J Physiol. 235:1978;H361-H366.